The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
Clinical trial NCT05972564 · RECRUITING
Trial details
- NCT number
- NCT05972564
- Sponsor
- Vanderbilt University Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-06
- Primary completion
- 2026-09-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.